Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2000
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1012179A2 Cysteine rich receptors: trail
06/28/2000EP1012178A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
06/28/2000EP1012177A1 Estrogen receptor
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1011743A1 Loading and release of water-insoluble drugs
06/28/2000EP1011737A2 Method for treating proliferative diseases by therapy
06/28/2000EP1011733A1 Compositions and methods for enhancing delivery of therapeutic agents to cells
06/28/2000EP1011726A2 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011717A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
06/28/2000EP1011705A2 Conjugates targeted to the interleukin-2 receptor
06/28/2000EP1011703A1 Nucleosome-based anti-tumor compositions
06/28/2000EP1011687A1 13-deoxyanthracycline derivatives and processes for preparing them
06/28/2000EP1011682A2 Hormonal contraceptive
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP1011665A1 Heterocyclic agents
06/28/2000EP1011648A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
06/28/2000EP1011638A1 Small particle liposome aerosols for delivery of anti-cancer drugs
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011329A1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
06/28/2000EP0754057B1 Compositions and methods for vaccines comprising alpha-galactosyl epitopes
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258319A Vector
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258280A Cyanoamidines as cell proliferation inhibitors
06/28/2000CN1258279A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258278A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258277A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258276A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/28/2000CN1053838C Synergism of TNF and IL-4
06/27/2000US6080878 Method of preparing 16-dehydro vitamin D compounds
06/27/2000US6080877 Taxanes
06/27/2000US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080769 Imidazolidin-4-one derivatives useful as anticancer agents
06/27/2000US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080739 Colchicine-skeleton compounds, their use as medicaments and compositions containing them
06/27/2000US6080733 Thioureido-cyclodextrins, utilized in particular to solubilize anti-tumor, and antiparasitic agents and their preparation processes
06/27/2000US6080731 Dinucleoside-5', 5'-pyrophosphates administered to treat HIV
06/27/2000US6080728 Inhibiting tumor growth
06/27/2000US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling
06/27/2000US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia
06/27/2000US6080558 Polynucleotide encoding human growth regulator protein
06/27/2000US6080546 Antisense modulation of MEKK5 expression
06/27/2000US6080383 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer
06/27/2000CA2089553C Multidomain hematopoiesis stimulators
06/27/2000CA2001129C Tumour-inhibiting saccharide conjugates
06/22/2000WO2000036421A1 Use of vascular endothelial growth factor (vegf)
06/22/2000WO2000036118A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
06/22/2000WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036104A1 Pancreatic polypeptide zsig66
06/22/2000WO2000036099A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
06/22/2000WO2000035955A1 Use of oestrogen receptor variants in anticancer therapy
06/22/2000WO2000035950A2 Reagents and methods useful for detecting diseases of the breast
06/22/2000WO2000035949A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
06/22/2000WO2000035946A1 Methods
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035930A1 Vanadium compounds for treating cancer
06/22/2000WO2000035924A1 Camptothecin analogs and methods of preparation thereof
06/22/2000WO2000035921A1 4,5-pyrazinoxindoles as protein kinase inhibitors
06/22/2000WO2000035920A2 4,5-azolo-oxindoles
06/22/2000WO2000035917A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
06/22/2000WO2000035911A1 Heteroaryl-cyclic acetals
06/22/2000WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035865A2 Tubulin-binding agents
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035856A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035486A1 Soluble compositions of toremifene
06/22/2000WO2000035485A1 Soluble compositions of triphenylethylene antiestrogens
06/22/2000WO2000035469A2 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER
06/22/2000WO2000035455A1 Heteroaryl-aryl ureas as igf-1 receptor antagonists
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035430A2 Homer a new target of treating psychiatric disorders
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000035422A2 Method of administering a compound to multi-drug resistant cells
06/22/2000WO2000035407A2 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000WO2000035280A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000WO2000035279A1 Exo-s-mecamylamine formulation and use in treatment
06/22/2000WO2000015244A3 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
06/22/2000WO2000014106A9 Novel bag proteins and nucleic acid molecules encoding them
06/22/2000WO2000012709A3 Phelix: a testis-specific protein expressed in cancer
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000WO2000012122A3 Low-molecular fragments of hyaluronic acid for the preparation of vaccines
06/22/2000WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins
1 ... 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 ... 2211